Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children

Pediatric Infectious Disease Journal

Volumn 34, Issue 9, 2015, Pages 945-950

  Bruden, Dana J T ^a   Singleton, Rosalyn ^a,b   Hawk, Carolyn S ^c   Bulkow, Lisa R ^a   Bentley, Stephen ^a   Anderson, Larry J ^d   Herrmann, Leslie ^e   Chikoyak, Lori ^e   Hennessy, Thomas W ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Yukon Kuskokwim Health Corporation   (United States)

Author keywords

Alaska; Alaska Native; hospitalization; lower respiratory tract infection; respiratory syncytial virus; RSV; temperature

Indexed keywords

ALASKA NATIVE; ARTICLE; CHILD; CLIMATE; CROWDING (AREA); DEMOGRAPHY; DISEASE SEVERITY ASSESSMENT; DISEASE SURVEILLANCE; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITALIZATION; HOUSEHOLD; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEASON; SEASONAL VARIATION; TEMPERATURE; UNITED STATES; WEATHER; ALASKA; EPIDEMIOLOGICAL MONITORING; NEWBORN; PATHOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SOCIOECONOMICS;

ALASKA; CHILD, PRESCHOOL; CLIMATE; DEMOGRAPHY; EPIDEMIOLOGICAL MONITORING; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEASONS; SOCIOECONOMIC FACTORS;

EID: 84940054155     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000772     Document Type: Article

References (43)

1. Liu L, Johnson HL, Cousens S, et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151-2161.
2. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545-1555.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
4. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127-S132.
5. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54:1427-1436.
6. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588-598.
7. Singleton RJ, Holman RC, Folkema AM, et al. Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr. 2012;161:296-302.e2.
8. Karron RA, Singleton RJ, Bulkow L, et al. Severe respiratory syncytial virus disease in Alaska Native children. RSV Alaska Study Group. J Infect Dis. 1999;180:41-49.
9. Singleton RJ, Bruden D, Bulkow LR, et al. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season. Pediatr Infect Dis J. 2006;25:1116-1122.
10. Singleton RJ, Bulkow LR, Miernyk K, et al. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol. 2010;82:1282-1290.
11. Banerji A, Lanctôt KL, Paes BA, et al. Comparison of the cost of hospitalization for respiratory syncytial virus disease versus palivizumab prophylaxis in Canadian Inuit infants. Pediatr Infect Dis J. 2009;28:702-706.
12. Singleton RJ, Bruden D, Bulkow LR. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Pediatr Infect Dis J. 2007;26(11 Suppl):S46-S50.
13. Mullins JA, Lamonte AC, Bresee JS, et al. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22:857-862.
14. Tang JW, Loh TP. Correlations between climate factors and incidence-a contributor to RSV seasonality. Rev Med Virol. 2014;24:15-34.
15. Bloom-Feshbach K, Alonso WJ, Charu V, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013;8:e54445.
16. From the American Academy of Pediatrics: Policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694-1701.
17. Sloan C, Moore ML, Hartert T. Impact of pollution, climate, and sociodemographic factors on spatiotemporal dynamics of seasonal respiratory viruses. Clin Transl Sci. 2011;4:48-54.
18. Bulkow LR, Singleton RJ, De Byle C, et al. Risk factors for hospitalization with lower respiratory tract infections in children in rural Alaska. Pediatrics. 2012;129:e1220-e1227.
19. Hennessy TW, Ritter T, Holman RC, et al. The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska Natives. Am J Public Health. 2008;98:2072-2078.
20. Bulkow LR, Singleton RJ, Karron RA, et al; Alaska RSV Study Group. Risk factors for severe respiratory syncytial virus infection among Alaska Native children. Pediatrics. 2002;109:210-216.
21. Robin LF, Less PS, Winget M, et al. Wood-burning stoves and lower respiratory illnesses in Navajo children. Pediatr Infect Dis J. 1996;15:859-865.
22. American Community Survey, US Census Bureau. Available at: https://www.census.gov/acs/www/. Accessed January 9, 2014.
23. Miernyk K, Bulkow L, De Byle C, et al. Performance of a rapid antigen test (Binax NOW(R) RSV) for diagnosis of respiratory syncytial virus compared with real-time polymerase chain reaction in a pediatric population. J Clin Virol. 2010;50:240-243.
24. Singleton R, Malter A. Palivizumab prophylaxis recommendations-Alaska, 2013-14 RSV season. State Alaska Epidemiol Bull. 2014;20:2014.
25. Holman RC, Curns AT, Cheek JE, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics. 2004;114:e437-e444.
26. Singleton R, Dooley L, Bruden D, et al. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J. 2003;22:540-545.
27. McGuiness CB, Boron ML, Saunders B, et al. Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a National Surveillance System. Pediatr Infect Dis J. 2014;33:589-594.
28. du Prel JB, Puppe W, Gröndahl B, et al. Are meteorological parameters associated with acute respiratory tract infections? Clin Infect Dis. 2009;49:861-868.
29. Noyola DE, Mandeville PB. Effect of climatological factors on respiratory syncytial virus epidemics. Epidemiol Infect. 2008;136:1328-1332.
30. Welliver RC Sr. Temperature, humidity, and ultraviolet B radiation predict community respiratory syncytial virus activity. Pediatr Infect Dis J. 2007;26(11 Suppl):S29-S35.
31. Yusuf S, Piedimonte G, Auais A, et al. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007;135:1077-1090.
32. Donaldson GC. Climate change and the end of the respiratory syncytial virus season. Clin Infect Dis. 2006;42:677-679.
33. Paiva TM, Ishida MA, Benega MA, et al. Shift in the timing of respiratory syncytial virus circulation in a subtropical megalopolis: implications for immunoprophylaxis. J Med Virol. 2012;84:1825-1830.
34. Chang AB, Chang CC, O'Grady K, et al. Lower respiratory tract infections. Pediatr Clin North Am. 2009;56:1303-1321.
35. Yorita KL, Holman RC, Steiner CA, et al. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii. Pediatr Infect Dis J. 2007;26:1081-1088.
36. Dede A, Isaacs D, Torzillo PJ, et al. Respiratory syncytial virus infections in Central Australia. J Paediatr Child Health. 2010;46:35-39.
37. Bockova J, O'Brien KL, Oski J, et al. Respiratory syncytial virus infection in Navajo and White Mountain Apache children. Pediatrics. 2002;110 (2 Pt 1):e20.
38. Banerji A, Greenberg D, White LF, et al. Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children: a case-control study. Pediatr Infect Dis J. 2009;28:697-701.
39. Burgner D, Richmond P. The burden of pneumonia in children: an Australian perspective. Paediatr Respir Rev. 2005;6:94-100.
40. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003; 143(5 Suppl):S118-S126.
41. Singleton RJ, Valery PC, Morris P, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol. 2014;49:189-200.
42. Griffin MR, Zhu Y, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369:155-163.
43. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811-813.